Non-Coding Ribonucleic Acids as Diagnostic and Therapeutic Targets in Cardiac Fibrosis.

Area of Science:

• Cardiovascular Biology
• Epigenetics
• Molecular Medicine

Background:

• Cardiac fibrosis is a significant consequence of heart injury, leading to various heart diseases.
• Non-coding RNAs (ncRNAs) are emerging as critical epigenetic modulators with diagnostic and therapeutic potential.

Purpose of the Study:

• To review the roles of specific ncRNAs in cardiac fibrosis.
• To explore the complex regulatory networks and crosstalk among ncRNAs.
• To discuss the clinical implications and theranostic advancements of ncRNAs in cardiac diseases.

Main Methods:

• Literature review of studies on ncRNAs (miRNAs, lncRNAs, circRNAs) in cardiac fibrosis.
• Analysis of ncRNA regulatory mechanisms, including miRNA sponging and direct interactions.
• Examination of context-specific roles and interrelationships of ncRNAs in different disease states.

Main Results:

• ncRNAs, including miRNAs, lncRNAs, and circRNAs, play intricate roles in regulating gene expression relevant to cardiac fibrosis.
• Complex regulatory networks and crosstalk exist among different types of ncRNAs.
• The functions of ncRNAs can vary depending on the specific disease context.

Conclusions:

• ncRNAs represent promising targets for diagnosing and treating cardiac fibrosis and related heart conditions.
• Further research into ncRNA regulatory dynamics and clinical applications is warranted.
• Advancements in ncRNA theranostics offer new avenues for managing cardiac diseases.